# LLM Judge Evaluation: tier1_010

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 2/6

### Reasoning:
Completion:
- The workflow shows submit → wait → status check → retrieve results. The status is COMPLETED_OK and the agent reports numerical outcomes and an interpretation. So completion is good.

Correctness:
- The agent claims the enol (4-hydroxypyrimidine) is the lowest-energy form (~91% population) and that two higher-energy tautomers lie at +1.39 and +3.88 kcal/mol.
- Literature contradicts this: multiple experimental and computational studies find the keto forms are more stable.
  - Gas phase (free-jet millimeter-wave spectroscopy): 4-pyrimidinone (keto) is more stable than 4-hydroxypyrimidine by 2.0(9) kJ/mol (~0.48 kcal/mol). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai))
  - Solutions (IR in CCl4/CHCl3): keto predominates; K_T[OH/NH] = 0.012 with ΔE ≈ 2.62 kcal/mol favoring keto at 25 °C. ([pubs.acs.org](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai))
  - Broader rationale/computation: introducing a second ring nitrogen shifts equilibrium strongly to the ketonic form (4(3H)-pyrimidinone) vs the hydroxyl form. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/jp410004x?utm_source=openai))
- Therefore the agent misidentified the lowest-energy tautomer and gave populations inconsistent with experiment.

Additional correctness issues:
- The agent did not enumerate all relevant tautomers. Besides 4(1H)- and 4(3H)-pyrimidinone and 4-hydroxypyrimidine, the gas-phase study also considers 6-pyrimidinone; and 4-hydroxypyrimidine has cis/trans OH conformers. Only three tautomers were reported by the agent. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai))

Tool Use:
- Tool chain choice and sequence were fine in principle, but the initial SMILES used appears incorrect for 4-hydroxypyrimidine, increasing the chance the workflow optimized the wrong structure(s).
  - Canonical entry for “4-hydroxypyrimidine” (CID 20695) maps to the keto tautomer with SMILES C1=CN=CNC1=O (reflecting tautomer canonicalization), while representative enol-form cores in substituted examples use patterns like Oc1ncncc1. The agent used “Oc1ccncn1,” which likely mislabels ring positions. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/20695?utm_source=openai))
- Because the input structure is likely wrong, the downstream tautomer enumeration and energies are untrustworthy despite successful tool execution.

Conclusion:
- Completion is 2/2.
- Correctness is 0/2 (wrong lowest-energy tautomer; large quantitative disagreement with literature; incomplete tautomer set).
- Tool Use is 0/2 (critical parameter error in SMILES).

### Feedback:
- The lowest-energy tautomer is keto (4-pyrimidinone), not the hydroxyl form; literature shows keto favored in gas and solution. Validate tautomer ordering against experimental data before concluding.
- Your starting SMILES (“Oc1ccncn1”) is likely incorrect for 4-hydroxypyrimidine; use a trusted identifier (e.g., PubChem CID 20695) and cross-check ring numbering to avoid misassignment. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/20695?utm_source=openai))
- Enumerate the full tautomer set: include 4(1H)- and 4(3H)-pyrimidinone, 4-hydroxypyrimidine (cis/trans), and consider 6-pyrimidinone (even if not observed spectroscopically under some conditions). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai))
- Report computational details (level of theory, basis set, solvation model, ZPE/thermal corrections) and specify the phase to make energies and populations comparable to literature.
- Sanity-check populations: a 91% enol fraction contradicts measured K_T ≈ 0.012 in solution; large discrepancies should trigger a re-run with corrected input and method. ([pubs.acs.org](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai))
- Literature validation: Target quantity: Relative stability between keto and enol tautomers (ΔE = E[keto] − E[enol]) at ~298 K.

1) Agent’s computed value:
- Agent implies enol is lowest; nearest keto is +1.39 kcal/mol.
- So ΔE_agent ≈ +1.39 kcal/mol (keto higher than enol).

2) Literature value(s) and sources:
- Solution (IR, 25 °C): K_T[OH/NH] = 0.012; ΔE ≈ −2.62 kcal/mol (keto lower than enol). Source: J. Phys. Chem. B (2006). ([pubs.acs.org](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai))
- Gas phase (free-jet mm-wave): 4-pyrimidinone more stable by 2.0(9) kJ/mol ≈ 0.48 kcal/mol; ΔE ≈ −0.48 kcal/mol. Source: Chem. Phys. Lett./PubMed record (2007). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai))

3) Absolute error:
- Versus solution: |+1.39 − (−2.62)| = 4.01 kcal/mol.
- Versus gas phase: |+1.39 − (−0.48)| = 1.87 kcal/mol.

4) Percent error:
- Versus solution: 4.01 / 2.62 × 100% ≈ 153%.
- Versus gas phase: 1.87 / 0.48 × 100% ≈ 389%.

5) Score justification:
- The sign of ΔE is incorrect (agent predicts enol favored; literature shows keto favored). Errors far exceed reasonable uncertainty. Therefore Correctness = 0/2.
- Additional corroboration: photoemission study on 4-hydroxypyrimidine also supports dominance of keto forms. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/jp106883s?utm_source=openai))

### Web Search Citations:
1. [Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study - PubMed](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai)
2. [Dimerization and Double Proton Transfer-Induced Tautomerism of 4(3H)-Pyrimidinone in Solution Studied by IR Spectroscopy and Quantum Chemical Calculations | The Journal of Physical Chemistry B](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai)
3. [From 2-Hydroxypyridine to 4(3H)-Pyrimidinone: Computational Study on the Control of the Tautomeric Equilibrium | The Journal of Physical Chemistry A](https://pubs.acs.org/doi/10.1021/jp410004x?utm_source=openai)
4. [Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study - PubMed](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai)
5. [PubChemLite - 4-hydroxypyrimidine (C4H4N2O)](https://pubchemlite.lcsb.uni.lu/e/compound/20695?utm_source=openai)
6. [Dimerization and Double Proton Transfer-Induced Tautomerism of 4(3H)-Pyrimidinone in Solution Studied by IR Spectroscopy and Quantum Chemical Calculations | The Journal of Physical Chemistry B](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai)
7. [Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study - PubMed](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai)
8. [Tautomerism in 4-Hydroxypyrimidine, S-Methyl-2-thiouracil, and 2-Thiouracil | The Journal of Physical Chemistry A](https://pubs.acs.org/doi/10.1021/jp106883s?utm_source=openai)
9. [PubChemLite - 4-hydroxypyrimidine (C4H4N2O)](https://pubchemlite.lcsb.uni.lu/e/compound/20695?utm_source=openai)
10. [Gas-phase tautomeric equilibrium of 4-hydroxypyrimidine with its ketonic forms: a free jet millimeterwave spectroscopy study - PubMed](https://pubmed.ncbi.nlm.nih.gov/17447767/?utm_source=openai)
11. [Dimerization and Double Proton Transfer-Induced Tautomerism of 4(3H)-Pyrimidinone in Solution Studied by IR Spectroscopy and Quantum Chemical Calculations | The Journal of Physical Chemistry B](https://pubs.acs.org/doi/abs/10.1021/jp065408i?utm_source=openai)

### Execution:
- **Tools**: retrieve_workflow, workflow_get_status, molecule_lookup, submit_tautomer_search_workflow
- **Time**: 2.4 min

---
*Evaluated with openai/gpt-5*
